<--GAT-->

All-Cause Mortality Reduced in Heart Failure Patients with Lower Discharge Heart Rate

by U.S. Medicine

December 15, 2017

WASHINGTON — Although a lower heart rate is known to be linked with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF), not as much research is available on the association in patients with HF with preserved ejection fraction (HFpEF).

A study published in the Journal of the American College of Cardiology reported the results of a study examining discharge heart rate with outcomes in hospitalized patients with HFpEF.1

[Click on Image to See Enlarged Version]

Researchers from the Center for Health and Aging at the Washington, DC, VAMC and VA institutions around the nation focused on 8,873 hospitalized patients with HFpEF and an EF of 50% or greater in the Medicare-linked OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry. Of those patients, 6,286 had a stable heart rate, defined as 20 or less beats/min variation between admission and discharge. A subset of 38% had a discharge heart rate of less than 70 beats/min.

The researchers used propensity scores for discharge heart rate of less than 70 beats/min, estimated for each of the 6,286 patients, to create a cohort of 2,031 pairs of patients with heart rate less than 70 beats/min vs. 70 or higher beats/min, balanced on 58 baseline characteristics. Most of the 4,062 matched patients, with a mean age of 79, were women and only 10% were African-American.

Results indicated that during a total of six years, with a median 2.8 years, of follow-up, all-cause mortality was 65% vs. 70% for matched patients with a discharge heart rate less than 70 beats/min compared to those with heart rates 70 or higher beats/min, for a hazard ratio (HR) of 0.86. A heart rate of less than 70 beats/min was also associated with a lower risk for the combined endpoint of HF readmission or all-cause mortality – with an HR of 0.90 — but not with HF readmission (HR: 0.93)) or all-cause readmission (HR: 1.01).

Study authors pointed out that heart rhythm or use of beta-blockers had no effect on the results, concluding, “Among hospitalized patients with HFpEF, a lower discharge heart rate was independently associated with a lower risk of all-cause mortality, but not readmission.”

  1. Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction. JAm Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.PubMed PMID: 28982499.

Related Articles

VA Research Determines Which Beta Blocker Is Better in Heart Failure

ST. LOUIS—Current clinical guidelines recommend the use of beta blockers in all heart failure patients with with reduced ejection fraction (HFrEF). Which beta blocker to use—carvedilol or metoprolol succinate—remained unclear, however, according to a recent... View Article

New VA Analysis Refutes Link Between Heart Failure, Incident Cancer

With about 350,000 patients with heart failure diagnoses being treated in the VHA, recent studies suggesting that the cardiovascular condition increases risk of cancer have been worrisome.


U.S. Medicine Recommends


More From clinical topics home

Clinical Topics Home

Hypoglycemia Common in Hospice Patients Continuing Insulin Treatment

STATESBORO, GA—What factors can cause delays in initiation of initial disease-modifying antirheumatic drug, or DMARD, in patients newly diagnosed with rheumatoid arthritis (RA)? A retrospective cohort descriptive study used administrative data from the TRICARE program... View Article

Clinical Topics Home

VA Study Shows Kidney Disease Ups Diabetes Risk

STATESBORO, GA—What factors can cause delays in initiation of initial disease-modifying antirheumatic drug, or DMARD, in patients newly diagnosed with rheumatoid arthritis (RA)? A retrospective cohort descriptive study used administrative data from the TRICARE program... View Article

Clinical Topics Home

Longer LOS Doesn’t Reduce COPD Readmissions

Recent financial penalties for high risk-adjusted chronic obstructive pulmonary disease (COPD) readmissions have pushed hospitals to search for ways to reduce readmissions for chronic obstructive pulmonary disease, a new study notes.

Clinical Topics Home

Study Looks at Soldiers’ Pre-Deployment Respiratory Health

The respiratory health of military personnel deployed to Southwest Asia continues to be an issue of great concern in light of their exposures to a variety of environmental hazards.

Clinical Topics Home

Optimizing Treatment of Peripheral T-cell Lymphoma

Long-term survival in patients with aggressive peripheral T-cell lymphoma (PTCL) is generally poor, no clear consensus exists on optimal initial therapy, according to a new study.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up